Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Ueda

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Oncology Letters|June 11, 2017
Disseminated carcinomatosis of the bone marrow with disseminated intravascular coagulation as the first symptom of recurrent rectal cancer successfully treated with chemotherapy: A case report and review of the literatureHiroshi Takeyama, Tsutomu Sakiyama, Tomoko Wakasa, et al.
Investigational New Drugs|September 18, 2009
Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non-small cell lung cancerIsamu Okamoto, Masaki Miyazaki, Ryotaro Morinaga, et al.
Investigational New Drugs|August 27, 2013
A phase II study of cisplatin /S-1 in patients with carcinomas of unknown primary siteAsuka Tsuya, Takayasu Kurata, Akihiro Tamiya, et al.
Journal of Clinical Pharmacy and Therapeutics|April 1, 2020
Population pharmacokinetic analysis of esomeprazole in Japanese subjects with various CYP2C19 phenotypesMario Nagase, Hitoshi Shimada, Masahiro Nii, et al.
Cancer Chemotherapy and Pharmacology|November 13, 2015
Phase I study of nintedanib in combination with pemetrexed as second-line treatment of Japanese patients with advanced non-small cell lung cancerHaruko Daga, Koji Takeda, Hideaki Okada, et al.
Anticancer Research|December 11, 2013
Phase I pharmacokinetic study of S-1 granules and nedaplatin for advanced head and neck cancerHidetoshi Hayashi, Isamu Okamoto, Shinya Ueda, et al.
Cancer Medicine|January 10, 2014
Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinomaHisato Kawakami, Isamu Okamoto, Kyoichi Terao, et al.
Molecular Cancer Therapeutics|August 7, 2010
Phase I safety, pharmacokinetic, and biomarker study of BIBF 1120, an oral triple tyrosine kinase inhibitor in patients with advanced solid tumorsIsamu Okamoto, Hiroyasu Kaneda, Taroh Satoh, et al.
Lung Cancer (Amsterdam, Netherlands)|March 19, 2010
Dose-escalation study of pemetrexed in combination with carboplatin followed by pemetrexed maintenance therapy for advanced non-small cell lung cancerIsamu Okamoto, Koji Takeda, Haruko Daga, et al.
Medicine|September 9, 2020
Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases: A post hoc analysis of the WJOG4407G phase III studyAyumu Hosokawa, Kentaro Yamazaki, Chu Matsuda, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Oncology Letters|June 11, 2017
Disseminated carcinomatosis of the bone marrow with disseminated intravascular coagulation as the first symptom of recurrent rectal cancer successfully treated with chemotherapy: A case report and review of the literatureHiroshi Takeyama, Tsutomu Sakiyama, Tomoko Wakasa, et al.
Investigational New Drugs|September 18, 2009
Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non-small cell lung cancerIsamu Okamoto, Masaki Miyazaki, Ryotaro Morinaga, et al.
Investigational New Drugs|August 27, 2013
A phase II study of cisplatin /S-1 in patients with carcinomas of unknown primary siteAsuka Tsuya, Takayasu Kurata, Akihiro Tamiya, et al.
Journal of Clinical Pharmacy and Therapeutics|April 1, 2020
Population pharmacokinetic analysis of esomeprazole in Japanese subjects with various CYP2C19 phenotypesMario Nagase, Hitoshi Shimada, Masahiro Nii, et al.
Cancer Chemotherapy and Pharmacology|November 13, 2015
Phase I study of nintedanib in combination with pemetrexed as second-line treatment of Japanese patients with advanced non-small cell lung cancerHaruko Daga, Koji Takeda, Hideaki Okada, et al.
Anticancer Research|December 11, 2013
Phase I pharmacokinetic study of S-1 granules and nedaplatin for advanced head and neck cancerHidetoshi Hayashi, Isamu Okamoto, Shinya Ueda, et al.
Cancer Medicine|January 10, 2014
Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinomaHisato Kawakami, Isamu Okamoto, Kyoichi Terao, et al.
Molecular Cancer Therapeutics|August 7, 2010
Phase I safety, pharmacokinetic, and biomarker study of BIBF 1120, an oral triple tyrosine kinase inhibitor in patients with advanced solid tumorsIsamu Okamoto, Hiroyasu Kaneda, Taroh Satoh, et al.
Lung Cancer (Amsterdam, Netherlands)|March 19, 2010
Dose-escalation study of pemetrexed in combination with carboplatin followed by pemetrexed maintenance therapy for advanced non-small cell lung cancerIsamu Okamoto, Koji Takeda, Haruko Daga, et al.
Medicine|September 9, 2020
Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases: A post hoc analysis of the WJOG4407G phase III studyAyumu Hosokawa, Kentaro Yamazaki, Chu Matsuda, et al.
Pageof 6